Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Sensor Detects Antibodies to Gliadin, a Component of Gluten

By LabMedica International staff writers
Posted on 19 Nov 2008
Scientists in Spain and the United Kingdom have developed a fast test for identifying the food protein that triggers celiac disease, a difficult-to-diagnose digestive disease involving the inability to digest a protein called gluten that is present in wheat, oats, rye, and barley. More...
They have developed an electrochemical immunosensor that detects antibodies to the protein gliadin, which is a component of gluten.

The standard test for gliadin is an enzyme-linked immunosorbant assay (ELISA). The test using the new immunosensor took barely 90 minutes to detect gliadin in the parts per billion range compared to eight hours for the ELISA. Both tests were equally accurate but the new sensor would be easier to use at food manufacturing plants, the scientists note.

Avoiding food that contains gluten can be difficult for patients with celiac disease because gluten may be a hidden ingredient in unsuspected foods, such as soy sauce, canned soups, and licorice candy. Some prepared foods list gluten content on package labels, but identifying its presence is difficult and time-consuming.

The sensor could help millions of people avoid diarrhea, bloating, and other symptoms that occur when they unknowingly eat foods containing gluten.

The study was performed by Alex Fragoso, Ph.D. and Ciara O'Sullivan from the Universitat Rovirai I Virgili (Tarragona, Spain) and Kings College London (U.K), together with colleagues in Spain. It appeared in the online edition of Analytical Chemistry (American Society of Chemistry) on October 29, 2008.

Related Links:
Universitat Rovirai I Virgili
Kings College London


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Platelet Function Analyzer
PL-12
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.